Status quo interpretations of eligibility harm innovation
Blevins, Congressional Research Service Science and Technology Policy Analyst, and Hickey, Congressional Research Service legislative attorney, 24
[Emily G. Blevins and Kevin J. Hickey, 1-3-24, Emily is an Congressional Research Service Science and Technology Policy Analyst and Kevin is a Congressional Research Service legislative attorney, Congressional Research Service, “Patent-Eligible Subject Matter Reform: An Overview,” , accessed: 7-9-24, ES]
Other respondents reported negative effects on innovation as a result of the expansion of ineligible subject matter, especially in the life sciences sector. Some of these groups further warned of potential negative implications for the United States’ position as a global leader in innovation. For example, one representative of the biotechnology industry stated that current interpretations of patent subject matter eligibility standards had jeopardized the industry’s ability to develop and deliver “precision medicine, pharmaceutical treatments, and diagnostics” to patients.